Methods and apparatus for treatment of Parkinson's disease
US6166081A · kind A · utility
10Cited by
2References
12Claims
0Family size
Inventors
Key dates
| Filing date | Apr 7, 1999 |
| Grant date | Dec 26, 2000 |
| Priority date | — |
| Expiry date | Apr 7, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/195
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition for treatment of Parkinson's disease comprising a compound of levodopa dissolved in a non-degradative solvent which allows transdermal administrtion of levodopa. The compound of levodopa is an alkyl-ester of levodopa and the solvent is a formulation comprising a substantially non-aqueous solvent, a transdermal enhancer and a detergent. The alkyl-ester of levodopa is preferably levodopa-ethyl-ester (LDEE).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.